Advertisement
Screener

Lucid Diagnostics Inc. (LUCD) EBITDA

Lucid Diagnostics Inc. (LUCD) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$12.58M*; Operating income -$12.80M; Depreciation and amortization $224.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$11.89M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$13.8M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$11.54M*; Operating income -$11.76M; Depreciation and amortization $220.00K*.

Complete source-backed ebitda history.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$12.58M*-$12.80M$224.00K*(m)(m)$21.00K*-$11.30M*(m)$1.19M(m)$0.00
2026-03-31Reported-$11.89M(m)(m)(m)-946.82%$215.00K-$12.10M(m)$1.21M(m)$0.00
2025-12-31Reported-$13.8M(m)(m)(m)-917.69%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$11.54M*-$11.76M$220.00K*$1.21M-952.85%*(m)-$10.89M*(m)$1.27M(m)(m)
2025-06-30Reported-$11.16M*-$11.38M$222.00K*$1.16M-959.76%*$25.00K*-$10.55M*(m)$1.25M(m)$0.00
2025-03-31Reported-$12.27M(m)(m)(m)-1481.40%$93.00K-$12.46M(m)$1.43M(m)$0.00
2024-12-31Reported-$12.15M(m)(m)(m)-1015.29%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$11.48M*-$11.69M$215.00K*$1.17M-979.44%*(m)-$10.18M*(m)$1.67M(m)(m)
2024-06-30Reported-$10.96M*-$11.19M$229.00K*$976.00K-1123.26%*(m)-$11.48M*(m)$1.37M(m)(m)
2024-03-31Reported-$10.29M(m)(m)(m)-1028.07%(m)-$12.61M(m)$1.50M(m)(m)
2023-12-31Reported-$10.82M(m)(m)(m)-1040.77%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$10.50M*-$11.13M$625.00K*$783.00K-1341.38%*(m)-$8.78M*(m)$1.61M(m)(m)
2023-06-30Reported-$10.95M*-$11.58M$633.00K*$159.00K-6887.42%*(m)-$6.94M*(m)$1.83M(m)(m)
2023-03-31Reported-$13.71M(m)(m)(m)-3072.87%$17.00K-$7.12M(m)$1.89M(m)(m)
2022-12-31Reported-$14.36M(m)(m)(m)-12821.43%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$13.78M*-$14.38M$593.00K*$76.00K-18136.84%*$1.00M*-$6.35M*$0.00*$2.70M(m)(m)
2022-06-30Reported-$13.92M*-$14.63M$704.00K*(m)(m)$2.05M*-$13.30M*(m)$3.44M(m)(m)
2022-03-31Reported-$12.25M(m)(m)(m)-6479.89%$148.00K-$5.78M(m)$2.88M(m)(m)
2021-12-31Reported-$11.24M(m)(m)(m)-3746.67%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$6.51M*-$6.51M$0.00*(m)(m)$28.00K*-$2.18M*(m)$2.19M$8.00K(m)
2021-06-30Reported(m)-$6.02M(m)(m)(m)$1.00K*-$2.29M*(m)$1.87M$8.00K(m)
2021-03-31Reported(m)-$3.65M(m)(m)(m)$9.00K-$3.31M(m)$1.75M$6.00K(m)
2020-09-30Reported(m)-$2.02M(m)(m)(m)(m)(m)(m)$1.22M$3.00K(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$48.77M(m)(m)(m)-1036.29%$197.00K-$46.48M(m)$5.68M(m)$0.00
2024-12-31Reported-$44.89M(m)(m)(m)-1032.79%$296.00K-$44.14M(m)$5.99M(m)$0.00
2023-12-31Reported-$45.98M(m)(m)(m)-1893.86%(m)-$32.82M(m)$7.25M(m)(m)
2022-12-31Reported-$54.32M(m)(m)(m)-14407.16%$3.20M-$29.68M$100.00M$11.26M(m)(m)
2021-12-31Reported-$27.42M(m)(m)(m)-5483.00%$862.00K-$17.67M(m)$9.30M$21.00K(m)
2020-12-31Reported(m)-$8.28M(m)(m)(m)(m)-$5.63M(m)$5.44M$7.00K(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
Profound Medical Corp. (PROF)$0.206B-7.37
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Apyx Medical Corp (APYX)United States$0.120B-21.85
PRO DEX INC (PDEX)United States$0.234B13.64
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Microbot Medical Inc. (MBOT)$0.089B-7.97
LENSAR, Inc. (LNSR)United States$0.087B2.02
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17